24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publication dates

Gene Therapy Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Cancer, Therapeutics, more »


 
1-10 of 34 reports for Gene Therapy

Global miRNA Market 2015-2019

Global miRNA Market 2015-2019

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About miRNAs miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study ...

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Associated viral vectors. The company offers product for metabolic, muscle, hematologic, ocular and neurodegenerative disorders. It develops products in the areas of gene therapy, gene modulation, protein ...

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... In the fields of regenerative medicine and gene therapy. The company provides therapies for autologous and heterologous transplants. Molmed is headquartered in milano, italy.Molmed s.P.A. Key recent ...

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... On umbilical cord blood, which is used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... To the patient. The company has a strategic collaboration with celgene corporation to discover, develop and commercialize disease-altering gene therapy products in oncology. Genetix is headquartered in cambridge ...

Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 99 drugs. gene therapy in oncology drug pipeline update lists all drugs and gives you a progress analysis ...

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

KOLON LIFE SCIENCE INC. (Symbol:102940) SWOT Analysis, Strategy, Revenues and Profits

KOLON LIFE SCIENCE INC. (Symbol:102940) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • October 2014
  • by Global Data

... Antibacterial agents, high refraction monomer, therapeutic protein drug and cell-mediated gene therapy. Kolon's technology platform produces and utilizes protein for human body by performing gene manipulation ...

Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

About 400 reports for Gene Therapy

Download Unlimited Documents from Trusted Public Sources

Takara Bio Annual Report 2014

  • Annual Report
  • January 2014
    38 pages
  • Japan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.